Show
Sort by
-
- Journal Article
- A1
- open access
Structural changes in the sacroiliac joint on MRI and relationship to ASDAS inactive disease in axial spondyloarthritis : a 2-year study comparing treatment with etanercept in EMBARK to a contemporary control cohort in DESIR
-
Data-driven definitions for active and structural MRI lesions in the sacroiliac joint in spondyloarthritis and their predictive utility
-
- Journal Article
- A1
- open access
Validation of the self-administered comorbidity questionnaire adjusted for spondyloarthritis : results from the ASAS-COMOSPA study
-
- Journal Article
- A1
- open access
Induction of sustained clinical remission in early axial spondyloarthritis following certolizumab pegol treatment : 48-week outcomes from C-OPTIMISE
-
- Journal Article
- A1
- open access
Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease : data from the Swiss Clinical Quality Management cohort
-
- Journal Article
- A1
- open access
Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W)
-
Prevalence of comorbidities and risk factors for comorbidities in patients with spondyloarthritis in Latin America : a comparative study with the general population and data from the ASAS-COMOSPA study
-
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological diseasemodifying anti-rheumatic drugs (COAST-V) : 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial
-
- Journal Article
- A1
- open access
Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target : 2017 update of recommendations by an international task force
-
- Journal Article
- A1
- open access
The performance of different classification criteria sets for spondyloarthritis in the worldwide ASAS-COMOSPA study